Christopher Dawes & Mary Leonard - Day 2 Welcome Remarks

TL;DR

The Child X Conference highlights cutting-edge research and advancements in children's health, with a focus on conception, development, and technology.

Transcript

good morning my name is Mary Leonard and it's my pleasure on behalf of the program committee to welcome you back as to the meeting and start the day in thinking about the day yesterday it's really quite extraordinary to see such state-of-the-art science on conception and pregnancy and the newborn infant and I can't think of a better place to do tha... Read More

Key Insights

• 👨‍🔬 The Child X Conference showcased groundbreaking research on blastocyst development, embryo selection, and blastocyst viability assessment, revolutionizing our understanding of conception.
• 👶 The Chief of the Maternal Child Health Bureau presented inspiring progress in maternal and child health, emphasizing the importance of a healthy future generation.
• 🍉 Advances in epigenetics, predictive immune signatures, and placental communication provide valuable insights into development to term and potential biomarkers.
• 🙂 The session on newborn screening and genetic advances shed light on the genetics of lung development and the repurposing of screening for acquired diseases.
• 🧠 The integration of behavioral techniques with advanced neural imaging offers exciting possibilities in understanding brain pathways.

Questions & Answers

Q: What were some of the key highlights from the conference sessions on conception?

The sessions on conception introduced groundbreaking models for blastocyst development heterogeneity, innovative software technology for blastocyst viability assessment, and pioneering work on embryo selection.

Q: What was discussed in the presentation by the Chief of the Maternal Child Health Bureau?

The Chief highlighted the substantial progress made in maternal and child health across the country, showcasing the Bureau's efforts in improving the full spectrum of maternal and child health.

Q: What insights were shared during the session on development to term?

The session on development to term presented state-of-the-art epidemiology work on epigenetics, the predictive immune signatures technology, the role of the placenta as an endocrine organ, and proteomic analysis for biomarkers and pathways related to complement immune function and clotting.

Q: What were some of the advancements discussed in the session on technology and innovation?

The session on technology and innovation discussed revolutions in neuroscience, the concept of the connectome genomics, advancements in artificial placenta technology for premature infants, and innovations in perinatal care from the Biodesign school.

Summary & Key Takeaways

• The conference featured sessions on blastocyst development, embryo selection, and blastocyst viability assessment, presenting paradigm-shifting models and innovative technologies.

• The Chief of the Maternal Child Health Bureau, Michael Liu, showcased the significant progress made in maternal and child health nationwide.

• Presentations on epigenetics, predictive immune signatures, placental communication, and proteomic analysis provided insights into development to term and potential biomarkers.

• The implications on newborn screening for acquired diseases and the genetics of lung development were discussed, along with advancements in behavioral techniques and neural imaging.

• The conference also highlighted the revolutionary potential of neuroscience, artificial placenta technology, and innovations in perinatal care.